• The management of Stallion India Fluorochemicals Limited will conduct an Analyst/Investor Meeting on Tuesday, 8th September 2026.
  • The meeting will be conducted virtually at the Registered Office of the Company.
  • The scheduled participant is Canara HSBC Life Insurance.
  • The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during this meeting.

Additional Notes Section

  • The disclosure includes a note that the schedule is subject to change due to exigencies on the part of the Company or the concerned analysts/investors, with any changes to be intimated to the Stock Exchanges where required.
  • No financial data, performance figures, or strategic updates were disclosed in this announcement.
  • The document was signed by Govind Rao, Company Secretary & Compliance Officer (Membership No.: ACS 47094) on 4th September 2026.